RESUMEN
Background and Objectives: In 2004, the Health Administration of Taiwan began to promote a hospital-based cancer screening quality improvement program, under the principle that "prevention is better than therapy". The aim of this study was to evaluate the effectiveness of colorectal cancer (CRC) screening in patients who received a fecal immunochemical test (FIT) at a hospital in central Taiwan. Materials and Methods: This was a retrospective study. Results: Fecal occult blood immunoassays for CRC screening were conducted in 58,891 participants, of whom 6533 were positive (positive detection rate 11.10%). The positive patients then underwent colonoscopy, and the detection rates of polyps and CRC accounted for 53.6% and 2.4% of all colonoscopy-confirmed diagnoses (3607), respectively. We further enrolled data from patients diagnosed with CRC at our hospital from 2010 to 2018. The patients with CRC were divided into two groups according to whether or not they had received fecal occult blood screening. Among the 88 patients with CRC by screening, 54 had detailed medical records including cancer stage. Of these 54 patients, 1 (1.8%) had pre-stage, 11 (20.4%) had stage I, 24 (44.4%) had stage II, 10 (18.5%) had stage III, and 8 (14.8%) had stage IV CRC. The early cancer detection rates of the screening and non-screening groups were 66.7% and 52.7%, respectively, and the difference was significant (p = 0.00130). Conclusions: In this study, screening with FIT significantly increased the early detection of CRC. The main advantage of FIT is the non-invasiveness and low cost. It is hoped that the further adoption of early screening can increase the detection rates of colorectal polyps or early cancer to improve survival, reduce the high cost of subsequent cancer treatment, and reduce the burden on the patient and healthcare system.
Asunto(s)
Inmunoensayo , Tamizaje Masivo , Sangre Oculta , Neoplasias Colorrectales/diagnóstico , Inmunoensayo/métodos , Tamizaje Masivo/métodos , Taiwán/epidemiología , Detección Precoz del Cáncer , Humanos , Masculino , Femenino , Persona de Mediana Edad , AncianoRESUMEN
Incidence of colon cancer has increased rapidly in China. Although many colon cancer cell lines have been established previously, most of them were derived from patients from western countries. Epidemiological, clinical, cytogenetic, and molecular biological studies showed that there are considerable differences between Chinese and western countries colon cancer patients. Therefore, establishment of novel colon cancer cell line from Chinese is useful for studying the racial difference of this disease and can be important for studying the pathogenesis of colon cancer in China. In our laboratory, two novel continuous human colon cancer cell lines, SHT-1 and SHH-1, have been established in vitro from Chinese patients, and both cell lines have been passaged for 4 yr, and they have been continuously subcultured with more than 800 population doubling and without signs of senescence. Both cell lines were obtained from primary tumor tissues during colon cancer surgery. Cells grew rapidly with a doubling time of 36-39 h and a plating efficiency of 26-28%. These cells exhibited an epithelial morphology and expressed cytokeratin. Tumor developed in severe combined immunodeficient (SCID) mice 4-6 wk after inoculated subcutaneously with the cultured cancer cells. Karyotypic analysis and comparative genomic hybridization (CGH) analysis in SHT-1 cells revealed a hypertriploid modal number of 76 with numerous numerical and structural abnormalities previously linked to colon cancer. In another cell line (SHH-1), CGH analysis revealed that -1p13 was the only cytogenetic anomaly.
Asunto(s)
Pueblo Asiatico , Carcinoma/etnología , Línea Celular Tumoral , Neoplasias del Colon/etnología , Animales , Carcinoma/genética , Carcinoma/patología , Neoplasias del Colon/genética , Neoplasias del Colon/patología , Humanos , Cariotipificación , RatonesRESUMEN
BACKGROUND/AIMS: Esophageal varices are one of the most common complications (varices, ascites, hypersplenism and encephalopathy) of portal hypertension. Endoscopic sclerotherapy or band ligation is the first choice for esophageal varices today. However, immediate surgical intervention is always needed whenever endoscopic therapy fails to control acute bleeding. Therefore, a simple, effective and less time-consuming procedure is worthwhile for patients who needed immediate surgical treatment. METHODOLOGY: A modified gastroesophageal decongestion and splenectomy GEDS (Hassab) was performed on patients who need immediate surgical intervention for variceal bleeding. There were 15 consecutive patients who received this operative method and the outcome of all patients were reviewed. RESULTS: During follow-up, esophageal varices were resolved in 8 patients (62%), diminished in size in 3 patients (23%) and remain unchanged in 2 patients (15%). Gastric varices disappeared in all patients. The rebleeding rate was 23% in our studies. Encephalopathy was not found in all patients. Moreover, no surgical mortality was found by using this surgical method. CONCLUSIONS: In this study the modified gastroesophageal decongestion and splenectomy (Hassab) was an effective life-saving procedure for its safe, simple and less time-consuming advantages. No esophageal transection was performed in this procedure; therefore esophageal fistula, which had high mortality, did not occur. We believe that our procedure may perhaps be an alternative choice for patients who need immediate surgical intervention for bleeding varices.
Asunto(s)
Procedimientos Quirúrgicos del Sistema Digestivo/métodos , Várices Esofágicas y Gástricas/complicaciones , Várices Esofágicas y Gástricas/cirugía , Hemorragia Gastrointestinal/etiología , Hemorragia Gastrointestinal/cirugía , Adulto , Anciano , Anciano de 80 o más Años , Várices Esofágicas y Gástricas/prevención & control , Femenino , Hemorragia Gastrointestinal/prevención & control , Humanos , Masculino , Persona de Mediana Edad , Recurrencia , Esplenectomía , Resultado del TratamientoRESUMEN
Norcantharidin exhibits cytotoxicity in many cancer cell lines, including colorectal cancer (CRC) cells. Its cytotoxic potency on primary CRC cells and other normal constituent cells of the human body remains elusive. This study investigates whether norcantharidin differentially exhibits cytotoxicity on primarily isolated CRC cells and dermal fibroblasts. The in vitro chemosensitivity of norcantharidin was measured using a MTT tetrazolium assay and compared with 73 primary tumor cells from surgically excised colorectal tumors, six human CRC cell lines and dermal fibroblasts. Observations of cytotoxicity to primary tumor cells reveal significant differences among genders and histological types; however, drug-induced chemosensitivity was not correlated with age or clinical stages of CRC patients. Norcantharidin had a similar cytotoxic effect on primary tumor cells and CRC cell lines in a dose-dependent manner. In contrast, normal fibroblasts were more resistant to norcantharidin-induced cytotoxicity than CRC cells. DAPI staining results demonstrated that norcantharidin caused CRC cell apoptosis by nuclear fragmentation and chromatin condensation. The release of cytochrome c and the triggering of caspase-3, -8 and -9 activation mediated apoptotic induction. Conversely, pretreatment with caspases or mitogen-activated protein kinase (MAPK) inhibitors significantly suppressed norcantharidin-induced CRC cytotoxicity. These in vitro results suggest that norcantharidin may be a safe and effective anti-cancer drug for CRC.